LeapFrog Investments exits Goodlife Pharmacy to CFAO Healthcare
- Value
- Undisclosed
- Date
- 1 October 2026
- Transaction type
- Divestment
- Practice area
- Private Equity and Venture Capital
- Jurisdiction
- Kenya, Multi-jurisdictional
- Client
- LeapFrog Investments / Goodlife Pharmacy
Summary
LeapFrog Investments exits Goodlife Pharmacy to CFAO Healthcare. Client: LeapFrog Investments / Goodlife Pharmacy.
Advisers
Sources
Compiled by Meridian from the public announcements and filings listed under Sources.
- Bowmans press release, 19 March 2026 (https://bowmanslaw.com/press_releases/bowmans-lauded-at-the-dealmakers-east-africa-awards/); Additional adviser information submitted to Meridian (firm dataset, October 2026), pending verification: Kaplan & Stratton named on CFAO Healthcare’s acquisition of 69.9% of Africa Chemist & Beauty Care (Goodlife Pharmacy).
- DealMakers AFRICA, 2026-03-19
Spotted an error? Suggest a correction.
Related
Related reporting
Intelligence
Kenya’s National Payment System Bill 2026 proposes ten licence categories and higher capital
Bowmans analysed Kenya's National Payment System Bill 2026, which would replace the 2014 framework.
Intelligence
The London corridor: African firms are hiring English-law capacity instead of renting it
Olaniwun Ajayi recruited a former HSF Kramer Johannesburg office managing partner into its London office in July 2026. Read against three other moves, it describes a…
Intelligence
Brands, broadcast rights and code: what 99 IP-linked deals reveal about Africa’s IP market
Meridian tracked 99 IP-linked transactions across Africa from October 2024 to October 2026. Brand licences, content rights and software now set prices in African M&A.